The testing strategy has proven to be a key tool to prevent and reduce the spread of the virus.
Voden offers high performance tests in accordance with the recent WHO and EUDC recommendations, as indicated by the Ministerial Circular of 8 January 2021.
For serology, the test for IgM and IgG research is available and the imminent neutralization test for monitoring antibodies induced by vaccination. For antigen research, a rapid immunochromatographic swab with high sensitivity, capable of highlighting positivity even in asymptomatic subjects.
With the availability of the new gene vaccines, a specific antibody response to the S-RBD epitope of the Spike protein is induced.
The use of specific serological kits is essential for correct monitoring of vaccinated patients. Voden offers the best semi-quantitative kit, capable of detecting anti-S-RBD antibodies with the highest specificity and sensitivity.
Semi-quantitative immunochromatographic test for the determination of anti-SRBD antibodies
For IVD diagnostic use only
Analysis time 15 minutes
No tool is provided
Sensitivity 98.53%
Specificity 99.31%
Accuracy 99.09 %
FDA certification n. EUA203138
With the recent circular from the Ministry of Health dated 8 January 2021, second and latest generation rapid tests. They are basically equated to the RT-PCR molecular test
Due to the greater practicality of rapid tests and the speed of obtaining results, the rapid swab has become an irreplaceable tool in screening programs in the presence of a high prevalence of the virus
Immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 antigen in human samples from nasal, nasopharyngeal and oropharyngeal swabs.
The kit is able to detect the virus even in the presence of gene mutations of the Spike protein, known as English variant.
For professional IVD use only
Analysis time 15 minutes
Sensitivity 95.65%
Specificity 99.02%
Accuracy 97.89%
LoD < 2.5 x 102 pfu/mL (<1mio copie RNA)
Ministerial Registration no. 2002551
Test for the semiquantitative determination in immunofluorescence of IgM and IgG antibodies against SARS-CoV-2 from 10 uL of whole blood.
For professional IVD use only
Analysis time 10 minutes
Sensitivity 95.8%
Specificity 97.0 %
Validated by the CTS of the Emilia Romagna Region
Ministerial Registration no. 1941587
Via della Vigna, 2
20821 Meda MB | ITALY
Tel. 0362-344417
Tel. 0362-501028
© Copyright 2021 Voden Medical Instruments S.p.a.
CCIAA di Milano in data 16/1/2003 | P.IVA 03784450961 | REA 1701933 | Cap.Sociale € 1.000.000
Voden Medical Instruments è certificata ISO 9001:2015